Navigation Links
Spherix D-tagatose to be Supplied by Inalco SpA
Date:4/30/2008

BETHESDA, Md., April 30 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX) announced today that it has signed letters of intent with Inalco SpA, an Italy-based manufacturer of bulk pharmaceutical ingredients, to supply a portion of the D-tagatose used in the Spherix Phase 3 clinical trial of the unique sugar as a treatment for Type 2 diabetes. Inalco will also provide cGMP (current Good Manufacturing Practice) production batches of D- tagatose for the Spherix New Drug Application (NDA) and will hold a Drug Master File (DMF). The Phase 3 clinical trial is scheduled to be completed at the end of 2009. If the clinical trial demonstrates efficacy of D-tagatose as a treatment for Type 2 diabetes, Spherix plans an initial purchase of 100 metric tons of D-tagatose from Inalco and a long-term supply agreement. Financial terms were not disclosed.

"This is a significant accomplishment toward achieving our goal of putting in place all the elements needed for a complete NDA submission," said Claire Kruger, CEO of Spherix.

Spherix is currently seeking approval from the US Food and Drug Administration (FDA) in order to market D-tagatose nationwide as a drug. If granted US approval of its NDA, Spherix plans to also apply for approval of D-tagatose to treat diabetes in the European Union (EU).

Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on October 10, 2007.

Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in biotechnology, and provides technical and regulatory consulting services to biotechnology and pharmaceutical companies.

Spherix's Internet address is http://www.spherix.com.


'/>"/>
SOURCE Spherix Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Growth Achieved in Spherixs Health Sciences Consulting Business
2. Spherix Reports Second Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... 2017  This Report analyzes the worldwide markets for Pharmaceutical Contract ... Dosage Forms, and Liquid & Semi-solid Dosage Forms. The report provides ... Japan , Europe , ... Read the full report: http://www.reportlinker.com/p04707109-summary/view-report.html ... Annual estimates and forecasts are provided ...
(Date:2/20/2017)... Feb. 20, 2017 Report analyzes the ... the following Product Segments: Ambulatory Infusion Pumps, Enteral ... Pumps, PCA Infusion Pumps, and Syringe Infusion Pumps. ... US, Canada, Japan, Europe, Asia-Pacific, Latin America, and ... report: http://www.reportlinker.com/p04707120-summary/view-report.html Annual estimates and ...
(Date:2/20/2017)... 20, 2017  This report analyzes the worldwide markets for ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ... Rest of World. Read the full ... forecasts are provided for the period 2015 through 2022. ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... Silverado today is pleased ... open and operate a state-of-the-art memory care community in Alexandria, Virginia. The new community ... site just outside of Old Town. , The three-story community with underground parking ...
(Date:2/20/2017)... Pittsburgh, PA (PRWEB) , ... February 20, 2017 , ... ... mechanism of thyroid cancer, as well as a marker that may predict response to ... those with many other types of cancer as well. The new findings were published ...
(Date:2/20/2017)... ... February 20, 2017 , ... Today, ... Document Router (BDR), the first IoT device from Biscom designed to deliver confidential ... will debut BDR at HIMSS17 and will be conducting demonstrations at ...
(Date:2/20/2017)... ... 2017 , ... ReportingMD, a Population Health Software Company, is pleased to announce a move to ... location will triple the size of the previous location while bringing life back to a ... , “We are excited to expand our footprint to better serve our growing client ...
(Date:2/20/2017)... , ... February 20, 2017 , ... Chuck E. Cheese’s® ... Sensitive Sundays, a joint event at Chuck E. Cheese’s locations throughout New England, New ... special needs, the opportunity to experience the fun of visiting Chuck E. Cheese’s in ...
Breaking Medicine News(10 mins):